| Members |
targetComponentId |
| M1a (III): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement (finding) |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a (IIIA): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement without risk factors (finding) |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a (IIIB): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with one risk factor (finding) |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a (IIIC): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with two risk factors (finding) |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a: Non-regional lymph node or pulmonary metastasis (finding) |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a: non-regional lymph node metastasis (finding) |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1b (IV): All other metastatic sites (finding) |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b (IVA): All other metastatic sites without risk factors (finding) |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b (IVB): All other metastatic sites with one risk factor (finding) |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b (IVC): All other metastatic sites with two risk factors (finding) |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b: Bone(s) (finding) |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b: Distant metastasis other than to non-regional lymph nodes and lungs (finding) |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1c: Other site(s) (finding) |
cM1c |
| MV |
megavolt (qualifier value) |
| MYH9 macrothrombocytopenia syndrome (disorder) |
MYH9 related disease |
| Machine tool operator |
Machine-tool operator (general) |
| Mackerel - dietary |
Mackerel (substance) |
| Macrolide overdose |
Macrolide antibacterial overdose (disorder) |
| Mafenide acetate 5% powder (product) |
Product containing only mafenide (medicinal product) |
| Mafenide acetate 85mg/g conventional release cutaneous cream (product) |
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| Mafenide acetate 85mg/g cream (product) |
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| Magaldrate 800mg/5mL suspension (product) |
Product containing precisely magaldrate 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Magnesium aspartate hydrochloride (product) |
Product containing magnesium aspartate (medicinal product) |
| Magnesium chloride 200mg/mL injection solution ampule (product) |
Product containing only magnesium chloride in parenteral dose form (medicinal product form) |
| Magnesium citrate 17.7g/sachet powder (product) |
Product containing only magnesium citrate (medicinal product) |
| Magnesium salicylate 467mg caplet (product) |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| Magnesium salicylate 467mg conventional release oral tablet |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| Magnesium salicylate 500mg caplet (product) |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| Magnesium salicylate 500mg conventional release oral tablet |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| Magnesium supplement (substance) |
Magnesium compound |
| Magnesium trisilicate+belladonna 0.15mg tablet (product) |
Belladonna alkaloid and magnesium trisilicate only product |
| Magnesium-based antacid (substance) |
Magnesium compound |
| Major amblyoscope |
Major amblyoscope (physical object) |
| Major depressive disorder clinical management plan (qualifier value) |
Major depressive disorder clinical management plan |
| Major puerperal infection |
Postnatal infection |
| Major salivary gland TNM finding (finding) |
American Joint Committee on Cancer allowable value |
| Making obscene telephone calls |
Telephone scatologia |
| Malathion 1% cream shampoo (product) |
Malathion 10 mg/mL shampoo |
| Male erectile disorder (disorder) |
Erectile dysfunction |
| Male pelvic peritonitis |
Pelvic peritonitis |
| Maleic anhydrid specific extract (product) |
Maleic anhydride |
| Malignant adenomatous neoplasm - category (morphologic abnormality) |
Malignant adenomatous neoplasm (morphologic abnormality) |
| Malignant epithelial neoplasm - category (morphologic abnormality) |
Malignant epithelial neoplasm |
| Malignant fibrohistiocytic neoplasm - category (morphologic abnormality) |
Malignant fibrohistiocytic neoplasm (morphologic abnormality) |
| Malignant glioma - category (morphologic abnormality) |
Malignant glioma |
| Malignant histiocytic neoplasm - category (morphologic abnormality) |
Malignant histiocytic neoplasm (morphologic abnormality) |
| Malignant histiocytosis |
Malignant histiocytosis |
| Malignant hypothermia due to anesthetic |
Hypothermia caused by anesthetic (finding) |
| Malignant lymphangioma |
Lymphangiosarcoma |
| Malignant lymphoma - category |
Malignant lymphoma |
| Malignant lymphoma, centroblastic, diffuse |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, centroblastic-centrocytic, diffuse (morphologic abnormality) |
Malignant lymphoma, mixed small and large cell, diffuse (morphologic abnormality) |
| Malignant lymphoma, centrocytic |
Mantle cell lymphoma |
| Malignant lymphoma, diffuse (morphologic abnormality) |
Non-Hodgkin lymphoma |
| lymphome malin diffus à grandes cellules B, sans sous-type dans la Classification Internationale des Maladies pour l'Oncologie (anomalie morphologique) |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, large cell, cleaved, diffuse (morphologic abnormality) |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, large cell, noncleaved, diffuse |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, lymphoblastic (morphologic abnormality) |
Precursor cell lymphoblastic lymphoma |
| Malignant lymphoma, lymphocytic, intermediate differentiation, nodular |
Non-Hodgkin lymphoma |
| Malignant lymphoma, lymphocytic, poorly differentiated, nodular |
Follicular lymphoma, grade 1 |
| Malignant lymphoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Malignant lymphoma |
| Malignant lymphoma, small cell, noncleaved, diffuse |
Non-Hodgkin lymphoma |
| Malignant lymphoma, small cleaved cell, diffuse |
Non-Hodgkin lymphoma |
| Malignant lymphomatous polyposis (morphologic abnormality) |
Mantle cell lymphoma |
| Malignant mastocytosis |
Malignant mastocytosis (morphologic abnormality) |
| Malignant melanocytic lesion |
Malignant melanoma |
| Malignant melanoma - category (morphologic abnormality) |
Malignant melanoma |
| Malignant melanoma of cornea |
Malignant melanoma of conjunctiva |
| Malignant melanoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Malignant melanoma |
| Malignant myoepithelioma (morphologic abnormality) |
Malignant myoepithelioma |
| Malignant neoplasm of bone and articular cartilage (disorder) |
Primary malignant neoplasm of bone |
| Malignant neoplasm of lymphoid AND/OR histiocytic tissue (disorder) |
Non-Hodgkin's lymphoma (clinical) |
| Malignant neoplasm of metacarpal bones of foot |
Malignant neoplasm of metatarsal bone of foot (disorder) |
| Malignant neoplasm of middle lobe of lung |
Malignant neoplasm of middle lobe of right lung (disorder) |
| Malignant neoplasms (& carcinoma) |
Carcinoma (morphologic abnormality) |
| Malignant neoplasms (& carcinoma) (disorder) |
Carcinoma (morphologic abnormality) |
| Malignant neoplastic process |
Neoplasm, benign (morphologic abnormality) |
| Malignant nerve sheath tumor - category (morphologic abnormality) |
Malignant nerve sheath tumour |
| Malignant teratoma - category (morphologic abnormality) |
Malignant teratoma (morphologic abnormality) |
| Malignant tumour of body of uterus (disorder) |
Malignant neoplasm of body of uterus (disorder) |
| Malignant tumour of endocrine gland (disorder) |
Malignant neoplasm of endocrine gland (disorder) |
| Malignant tumour of nervous system (disorder) |
Malignant neoplasm of nervous system (disorder) |
| Malignant tumour of skin (disorder) |
Malignant neoplasm of skin (disorder) |
| Malignant tumour of soft tissue of lower limb (disorder) |
tumeur maligne primaire des tissus mous d'un membre inférieur |
| Malignant tumour of soft tissue of upper limb (disorder) |
Primary malignant neoplasm of soft tissues of upper limb (disorder) |
| Malignant, metastatic site |
Neoplasm, metastatic |
| Malignant, uncertain whether primary or metastatic site |
Neoplasm, malignant, uncertain whether primary or metastatic |
| Malingerer |
simulation d'une maladie |
| Malingering (finding) |
simulation d'une maladie |
| Malnutrition clinical management plan (qualifier value) |
Malnutrition clinical management plan (record artifact) |
| Malocclusion (disorder) |
malocclusion des dents (trouble) |
| Malocclusion due to finger habits (disorder) |
Malocclusion due to sucking habits |
| Malposition of fetus (disorder) |
Malpresentation of fetus |
| Mammalian type C oncovirus group |
Mammalian group Gammaretroviruses (organism) |
| Mammography and biopsy of left breast (procedure) |
Mammography guided biopsy of left breast |
| Mammography and biopsy of right breast (procedure) |
Mammography guided biopsy of right breast |
| Mammography assessment scale 0 (out of 5) - Additional imaging needed |
Mammography assessment (Category 0) - Need additional imaging evaluation (finding) |
| Mammography assessment scale 1 (out of 5) - Negative |
Mammography assessment (Category 1) - Negative (finding) |
| Mammography assessment scale 2 (out of 5) - Benign |
Mammography assessment (Category 2) - Benign finding (finding) |
| Mammography assessment scale 3 (out of 5) - Probably benign |
Mammography assessment (Category 3) - Probably benign finding, short interval follow-up (finding) |
| Mammography assessment scale 4 (out of 5) - Abnormality suspicious for malignancy |
Mammography assessment (Category 4) - Suspicious abnormality, biopsy should be considered (finding) |
FHIR